AI assistant
BIO-TECHNE Corp — Director's Dealing 2018
Aug 9, 2018
30718_dirs_2018-08-09_c4842a93-5de8-4ebb-8f1a-43b6ce0d8b4f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2018-08-07
Reporting Person: Furlow Brenda S. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-07 | Common Stock | M | 959.00 | $0.00 | Acquired | 2627.00 | Direct |
| 2018-08-07 | Common Stock | F | 438.00 | $180.14 | Disposed | 2189.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-08-07 | Restricted Stock Units | $ | M | 959.00 | Disposed | Common Stock (959.00) | Direct | |
| 2018-08-07 | Restricted Stock Units | $ | D | 241.00 | Disposed | Common Stock (241.00) | Direct | |
| 2018-08-07 | Stock Options (Right to buy) | $108.49 | D | 1505.00 | Disposed | 2022-08-07 | Common Stock (1505.00) | Direct |
| 2018-08-08 | Restricted Stock Units | $ | A | 1374.00 | Acquired | Common Stock (1374.00) | Direct | |
| 2018-08-08 | Stock Options (Right to buy) | $177.32 | A | 9786.00 | Acquired | 2025-08-08 | Common Stock (9786.00) | Direct |
| 2018-08-08 | Stock Options (Right to buy) | $177.32 | A | 7339.00 | Acquired | 2025-08-08 | Common Stock (7339.00) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Units | $ | Common Stock (1759.00) | 1759.00 | Direct | |
| Restricted Stock Units | $ | Common Stock (1724.00) | 1724.00 | Direct | |
| Stock Option (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (10000.00) | 10000.00 | Direct |
| Stock Option (Right to Buy) | $94.35 | 2021-08-12 | Common Stock (15000.00) | 15000.00 | Direct |
| Stock Options (Right to buy) | $125.05 | 2024-08-09 | Common Stock (9503.00) | 9503.00 | Direct |
| Stock Options (Right to buy) | $125.05 | 2024-08-09 | Common Stock (12760.00) | 12760.00 | Direct |
| Stock Options (Right to buy) | $106.59 | 2023-08-18 | Common Stock (14476.00) | 14476.00 | Direct |
| Stock Options (Right to buy) | $106.59 | 2023-08-18 | Common Stock (10857.00) | 10857.00 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F10: Vest 3,167 shares each on 8/9/2018, 8/9/2019 and 3,168 shares each on 8/9/2020, 8/9/2021.
F11: Vests 3,619 shares on each of 8/18/17, 8/18/18, 8/18/19 and 8/18/20.
F2: On 8/7/2018, the Board of Directors authorized discretionary vesting for 959 performance RSUs. The remainder of the performance RSUs were forfeited.
F3: On 8/7/2018, the Board of Directors authorized discretionary vesting for 5,995 performance options. The remainder of the performance options were forfeited.
F4: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F5: Vests 2,447 shares each on 8/8/2019, 8/8/2020, and 2,446 shares each on 8/8/2021, 8/8/2022
F6: Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7: Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8: 2,500 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
F9: 3,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.